{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-032650","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2023-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.798980+00:00","generated_at":"2026-06-18T02:02:36.829385+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"First Wave BioPharma raises $4.0M in private placement of common stock and warrants","bullets":["Gross proceeds ~$4.0M; issue of 1,023,018 shares/pre-funded warrants and 2,046,036 common warrants.","Price $3.91 per share/pre-funded warrant; common warrants exercise price $3.66, 5-year term.","Pre-funded warrants exercisable at $0.0001; closing expected March 15, 2023.","Roth Capital Partners acts as exclusive placement agent; proceeds for working capital.","Company to file resale registration statement with SEC within 30 days or 5 days after annual report."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-032650","json":"https://secwatch.observer/filing/0001104659-23-032650.json","markdown":"https://secwatch.observer/filing/0001104659-23-032650.md","text":"https://secwatch.observer/filing/0001104659-23-032650.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923032650/0001104659-23-032650-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923032650/tm239569d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T02:02:36.829385+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2db8fc2d57d904dc76e2871cfdc92ae9c6dc2915","claim":"GridAI Technologies Corp. entered into Securities Purchase Agreement with a single institutional investor valued at approximately $4.0 million (effective 2023-03-12).","evidence_excerpt":"On March 12, 2023, First Wave BioPharma, Inc., a Delaware corporation (the \"Company\"), entered into a Securities Purchase Agreement (the \"Purchase Agreement\") with a single institutional investor (the \"Purchaser\"), pursuant to which the Company agreed to issue, in a private placement (the \"Offering\"), an aggregate of (i) 128,000 shares (the \"Shares\") of the Company's common stock, par value $0.0001 per share (the \"Common Stock\"), (ii) pre-funded warrants (the \"Pre-Funded Warrants\") to purchase up to an aggregate of 895,018 shares (the \"Pre-Funded Warrant Shares\") and (iii) common warrants (the \"Common Warrants\" and collectively with the Pre-Funded Warrants, the \"Warrants\"), to purchase up to an aggregate of 2,046,036 shares of Common Stock (the \"Common Warrant Shares\" and collectively with the Pre-Funded Warrant Shares, the \"Warrant Shares\") at a purchase price of $3.91 per Share (or Pre-Funded Warrant in lieu thereof) and accompanying Common Warrant.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923032650/0001104659-23-032650-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a single institutional investor"},{"label":"Value","value":"approximately $4.0 million"},{"label":"Effective","value":"2023-03-12"}],"fact_type":"material_agreement"},{"claim_id":"40076cc04cf57205dbb405b16d4ff47a96ed1a74","claim":"GridAI Technologies Corp. entered into Registration Rights Agreement with the Purchaser (effective 2023-03-12).","evidence_excerpt":"In connection with the Offering, on March 12, 2023, the Company and the Purchaser entered into a Registration Rights Agreement (the \"Registration Rights Agreement\") pursuant to which the Company is required to file a registration statement with the Securities and Exchange Commission (the \"SEC\") to register for resale the Shares and the Warrant Shares.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465923032650/0001104659-23-032650-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"the Purchaser"},{"label":"Effective","value":"2023-03-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}